89 related articles for article (PubMed ID: 16489030)
1. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
2. Metastasis suppressor genes in clinical practice: are they druggable?
Gelman IH
Cancer Metastasis Rev; 2023 Dec; 42(4):1169-1188. PubMed ID: 37749308
[TBL] [Abstract][Full Text] [Related]
3. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
Chang CD; Chao MW; Lee HY; Liu YT; Tu HJ; Lien ST; Lin TE; Sung TY; Yen SC; Huang SH; Hsu KC; Pan SL
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166039. PubMed ID: 36683274
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase kinase 7 in inflammatory, cancer, and neurological diseases.
Caliz AD; Vertii A; Fisch V; Yoon S; Yoo HJ; Keaney JF; Kant S
Front Cell Dev Biol; 2022; 10():979673. PubMed ID: 36340039
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies.
Pranzini E; Raugei G; Taddei ML
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158815
[TBL] [Abstract][Full Text] [Related]
6. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer.
García-Hernández L; García-Ortega MB; Ruiz-Alcalá G; Carrillo E; Marchal JA; García MÁ
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008796
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin Prevents Loss of UCP2 in Hyperoxia via MKK4-p38 MAPK-PGC1α Signaling and Limits Oxygen Toxicity.
Raghavan S; Kundumani-Sridharan V; Kumar S; White CW; Das KC
Am J Respir Cell Mol Biol; 2022 Mar; 66(3):323-336. PubMed ID: 34890296
[TBL] [Abstract][Full Text] [Related]
8. Minimal Residual Disease, Metastasis and Immunity.
Badia-Ramentol J; Linares J; Gómez-Llonin A; Calon A
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33498251
[TBL] [Abstract][Full Text] [Related]
9. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
Ombrato L; Montagner M
Front Oncol; 2020; 10():594514. PubMed ID: 33251149
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.
Chiabotto G; Grignani G; Todorovic M; Martin V; Centomo ML; Prola E; Giordano G; Merlini A; Miglio U; Berrino E; Napione L; Isella C; Capozzi F; Basiricò M; Marsero C; Gerardi I; Venesio T; Sangiolo D; Aglietta M; D'Ambrosio L; Pignochino Y
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32531992
[TBL] [Abstract][Full Text] [Related]
11. FOXO transcription factor family in cancer and metastasis.
Jiramongkol Y; Lam EW
Cancer Metastasis Rev; 2020 Sep; 39(3):681-709. PubMed ID: 32372224
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer.
Kumar S; Principe DR; Singh SK; Viswakarma N; Sondarva G; Rana B; Rana A
Pharmaceuticals (Basel); 2020 Jan; 13(1):. PubMed ID: 31936067
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy.
Neophytou CM; Kyriakou TC; Papageorgis P
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817646
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
Curtis M; Kenny HA; Ashcroft B; Mukherjee A; Johnson A; Zhang Y; Helou Y; Batlle R; Liu X; Gutierrez N; Gao X; Yamada SD; Lastra R; Montag A; Ahsan N; Locasale JW; Salomon AR; Nebreda AR; Lengyel E
Cell Metab; 2019 Jan; 29(1):141-155.e9. PubMed ID: 30174305
[TBL] [Abstract][Full Text] [Related]
15. A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl
Lee HR; Leslie F; Azarin SM
J Biol Eng; 2018; 12():12. PubMed ID: 30127847
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
[No Abstract] [Full Text] [Related]
17. Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.
Stramucci L; Pranteda A; Bossi G
Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29751559
[TBL] [Abstract][Full Text] [Related]
18. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.
Yadav AS; Pandey PR; Butti R; Radharani NNV; Roy S; Bhalara SR; Gorain M; Kundu GC; Kumar D
Front Oncol; 2018; 8():72. PubMed ID: 29616190
[TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressors: functional pathways.
Khan I; Steeg PS
Lab Invest; 2018 Feb; 98(2):198-210. PubMed ID: 28967874
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients.
Wang PN; Huang J; Duan YH; Zhou JM; Huang PZ; Fan XJ; Huang Y; Wang L; Liu HL; Wang JP; Huang MJ
Oncotarget; 2017 May; 8(21):34352-34361. PubMed ID: 28423721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
